Mar 14, 2019 / 01:30PM GMT
Kristen Marie Stewart - Barclays Bank PLC, Research Division - Research Analyst
Joining us here for the next session at the Barclays Global Healthcare Conference. I'm Kristen Stewart, the medical supplies and device analyst. It is my pleasure to have Axonics here to talk about their technology and their program, their recent IPO in the MedTech space. So a newer entry here into the public domain. With us we have Dan Dearen, the company's CFO. We did have a little bit of a schedule change as Ray was unavailable. So Ray, we miss you, hope you're doing well. But Dan, without further ado, I'll turn it over to you.
Danny L. Dearen - Axonics Modulation Technologies, Inc. - President & CFO
Thank you very much. Thank you for having us. Thanks to Barclays, we have a long-standing relationship with the firm. As she mentioned, I'm Dan Dearen, I'm the President, Cofounder and Chief Financial Officer of the company, and Ray sends his regards. It's a pleasure to be here today to talk to you about Axonics and our neuromodulation system to treat chronic overactive bladder.
Axonics Modulation Technologies Inc at Barclays Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot